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Abstract.  At low pH, the hemagglutinin  (HA) of 
influenza virus undergoes an irreversible conforma- 
tional change that potentiates its essential membrane 
fusion function.  We have probed the details of this 
conformational change using a panel of 14 anti-HA- 
peptide antibodies.  Whereas some antibodies reacted 
equally well with both the neutral and low-pH HA 
conformations,  others reacted to a  significantly greater 
extent with the low-pH form. The locations of the 
peptides recognized by the latter antibodies in the 
three-dimensional  HA structure indicated regions of 
the protein that change in response to low pH.  More- 
over, kinetic experiments suggested steps in the con- 
formational change.  In addition to their relevance to 
membrane fusion, our results show that anti-peptide 
antibodies can be used to study some types of biologi- 
cally important protein conformational changes. 
M 
ANY important  biological  processes are regulated 
by changes in protein conformation.  Whereas some 
conformational  changes have been analyzed in de- 
tail  by electron microscopy (10, 29), x-ray crystallography 
(23, 24), or nuclear magnetic  resonance spectroscopy (3), 
others have been less amenable to high-resolution  structural 
analysis.  An example  of the latter  is  the irreversible  low 
pH-induced conformational  change that activates the mem- 
brane fusion function of the influenza  virus hemagglutinin 
(HA,~ for review see reference 34). Whereas the structure 
of the neutral  pH form of the bromelain-released fragment 
of the HA (BHA) has been determined by x-ray diffraction 
analysis (35, 38), similar high-resolution  information  is not 
available for the acid conformation.  Attempts to understand 
the low pH conformation have therefore employed biochemi- 
cal (9, 26), electron microscopical (25), and immunological 
(5,  17, 32, 39) approaches.  Circular dichroism studies indi- 
cate that the neutral  and low-pH forms of the HA show no 
gross differences  in secondary structure (26).  Analyses of 
protease sensitivity  (9, 26) and studies with two antiprotein 
mAbs (5,  17, 32, 39) suggest that the contacts between the 
HA monomers are partially  dissociated upon acidification. 
Here, we have confirmed and extended these earlier inves- 
tigations  using a panel of 14 HA-specific anti-peptide anti- 
bodies (16, 22, 37). Given their predetermined specificity for 
particular  peptide segments,  we have  been able to probe 
1. Abbreviations  used in this paper: BHA, bromelain released fragment of 
hemagglutinin; CHA, complete hemagglutinin; HA, hemagglutinin. 
regions of the molecule not examined in the prior studies. In 
this manner we have gained more precise information  about 
the structure of the HA at low pH. Moreover,  we have used 
several of the anti-HA-peptide antibodies to monitor the ki- 
netics and the sequence of events involved in the transition 
of the HA to its low-pH "fusion-active"  state. 
Materials and Methods 
Cells, Virus, and Reagents 
CVA cells (African green monkey kidney cells) were cultivated in DME as 
previously described (14). The X:31 strain of influenza virus was grown in 
the allantoic cavity of ll-d embryonated chicken eggs and purified as previ- 
ously described (9).  Iodogen  was purchased from Pierce Chemical Co., 
Rockford, IL. Proteinase K was purchased from Boehringer Mannheim, In- 
dianapolis,  IN. ['2sI]Iodine and [sSS]methionine were obtained from Amer- 
sham Corp., Arlington Heights,  IL. Zysorbin was purchased from Zymed 
Laboratories, South  San Francisco,  CA.  All other biochemical reagents 
were obtained from the Sigma Chemical Co., St.  Louis,  MO. 
Purification and Radiolabeling of  BHA and CHA 
BHA trimers were isolated from egg grown X:31 (A/Aichi/1968)  influenza 
virus and iodinated to sp act 5-10 x  105 cpm/~g using the Iodogen proce- 
dure as described previously (9). The iodinated protein was then repurified 
on a 5-25% sucrose (wt/vol in Mes-saline buffer [MS, 20 mM 2-(N-mor- 
pholino)ethanesulfonic  acid, 130 mM NaCl, pH 7]) gradient by centrifuga- 
tion for 16 h at 250,000 g,  15~  in a SW41 rotor (Beckman Instruments, 
Inc., Fullerton, CA). The fractions from the 9S peak of this gradient (corre- 
sponding to BHA trimers) were pooled and judged to be >90% pure by 
SDS-PAGE.  To further insure the integrity  of the [I~I]BHA trimers la- 
beled and purified in this fashion, the protein was checked for its resistance 
to proteinase K digestion (9).  More extensive  iodination resulted  in the 
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not resistant to proteinase K (J. White, unpublished). 
[35S]CHA (the complete HA molecule including its transmembrane and 
cytoplasmic domains, nomenclature as in reference 25) trimers were pre- 
pared by infecting a monolayer of CV-I cells with X:31 influenza virus and 
then labeling the cells for 16 h with [35S]methionine  (0.5 mCi/75 cm  2 tis- 
sue culture flask). The infected cells were harvested in 1 ml of lysis buffer 
(1% NP40, 2 mM phenylmethylsulfonylfluoride,  2 gg/ml aprotinin in PBS). 
After removing nuclei and cell debris by centrifugation for 15 min at 12,000 g, 
we passed the extract over a 10-ml column of Ricin-Sepharose (9). The ma- 
terial that elnted with 0.2 M galactose was then concentrated, treated with 
10 I.tg/ml N-tosyl-L-phenyalanine  chloromethyl ketone-trypsin to cleave the 
protein from its precursor (CHAO)  to  active (CHA)  form,  and  further 
purified on a 5-25 % sucrose gradient as just described for BHA trimers ex- 
cept that the gradient contained 0.1% NP40. The fractions from the 9S-CHA 
trimer peak were pooled. 
Monomeric p25I]BHA was prepared by acidifying a sample of [125I]BHA 
trimers to pH 4.8 for 15 rain at 25~  (7). The sample was then neutralized 
and applied to a 5-25% sucrose (wt/vol) gradient in MS buffer, pH 7, con- 
taining 0.1% NP40. After centfifugation in an SW41 rotor for 16 h at 250~00 g, 
15~  700-gl fractions were collected from the bottom of the tube and the 
fractions containing the ~4S BHA monomers (about 10% of the total pro- 
tein applied to the gradient) were pooled. 
Acidification Reactions 
Samples containing ,'~300 ng of [125I]BHA per ml ("ol.3 nM BHA) in MS 
supplemented with 0.1% NP40 (unless otherwise stated) were adjusted to 
the indicated pH values by the addition of predetermined amounts of acetic 
acid. After incubation for the indicated time and at the indicated tempera- 
ture, the solutions were returned to pH 7.0 by the addition of predetermined 
amounts of NaOH. Solutions of [35S]CHA were similarly acidified except 
that the concentration of [35S]CHA was estimated to he ~15 nM. After in- 
cubation for the indicated time and at the indicated temperature, the samples 
were reneutralized with NaOH. For kinetic experiments, aliquots of acidi- 
fied BHA or CHA solutions were withdrawn at specified time points and 
immediately dispensed into tubes containing NaOH to restore the pH to 7.0. 
Immunoprecipitations 
Duplicate aliquots (100 gl each) containing "o2  ￿  104 cpm of [12SI]BHA or 
4  x  lit clam of [35SlCHA were incubated with the indicated antibody (50 
gl diluted into MS containing 0.1% NP40) for 16 h at4~  or, where stated, 
for 2 h at 25~  The antigen-antibody complexes were then absorbed with 
25 ~tl of Zysorbin (10% in PBS), washed two times with wash buffer (0.5 
M NaCI, 0.1 M Tris, pH 8.0, 0.1% NP40), and counted. These conditions 
were optimized for the precipitation of [125I]BHA with the rabbit anti-X:31 
virus polyclonal antiserum. The antibodies in the anti-virus antiserum are 
mainly directed against antigenic sites A and B of the HA trimer (35). The 
anti-peptide antisera were raised against synthetic peptides from the X:47 
strain of influenza virus (16, 22, 37). The X:47 and the X:31 strains are 95 % 
homologous (2, 21, 31). In all cases, the background values (0.2-0.7% of 
the input counts) of HA precipitated with an antiserum against preprolactin 
(1:50 dilution) were subtracted. Each experiment depicted was repeated at 
least twice. 
Results 
Because the accessibility of a peptide is likely to be one of 
the  major  factors  determining the  reactivity between  an 
anti-peptide antibody and an intact protein (15, 30),  site- 
specific anti-peptide antibodies should be able to distinguish 
differences in the surface accessibility of peptide sequences 
in different protein conformations. We therefore compared 
the reactivities of 14 anti-peptide antibodies to the HA of 
influenza virus in two of its conformational states: its neutral- 
pH trimeric form (35, 38) and its low-pH form. Because in 
the low-pH conformation some of the trimeric contacts are 
partially disrupted (7, 9, 25, 26),  one might expect certain 
anti-peptide antibodies to react preferentially with the mole- 
cule after acidification. Indeed, we identified several anti- 
HA-peptide antibodies that showed preferential binding to 
the low-pH state of the molecule. We then used these confor- 
mation-sensitive probes  to study the pH dependences and 
the apparent kinetics of several  steps  in the conformational 
change. 
Anti-Peptide Antibody Binding 
to Neutral vs. Low pH BHA 
The  anti-peptide  antisera used  in  this  study were  raised 
against synthetic peptides from almost all regions of the HA 
molecule (16, 22, 37). All have been shown previously to re- 
act with BHA or virus in solid-phase assays (16, 22, 37). To 
avoid possible conformational changes induced by adhesion 
of the HA to solid supports, we conducted quantitative im- 
munoprecipitations of lightly iodinated native BHA trimers 
or [35S]methionine labeled CHA trimers from solution. The 
antibody binding should then monitor the reactivity with in- 
tact protein in as close to "native" condition as possible. In 
all  cases  we  have assessed  the percent  of the  input  HA 
precipitated. Most prior immunoprecipitation studies with 
anti-peptide antibodies have only presented counts of radio- 
labeled protein precipitated, thus making it difficult to assess 
the efficiency of precipitation. 
Several of the antisera employed, including HA1  1-15 and 
HA2  15-29, are directed against peptides that are located 
mainly on the surface of the HA trimer (Fig. 1 B, bottom). 
Others are against peptides (see Fig. 1 B, top) that are rela- 
tively or completely inaccessible in the native neutral pH 
form of the HA either because they are buried in the trimer 
interface (HA1 98-106) or because they are masked in the 
monomer (HA1 305-328) by other peptide segments. Hence, 
for the latter group of peptides (Fig.  1 B, top),  an increase 
in peptide exposure should lead to an increase in anti-pep- 
tide antibody binding. 
The major finding presented in this paper is that the reac- 
tivities of anti-peptide antisera directed against sequences 
that lie partially or completely in the BHA trimer interface 
(Fig. 1 B, top) were markedly enhanced after a brief treat- 
ment of the BHA at low pH (Table I). The most striking ex- 
ample was  the  >300-fold  increase observed with a  mAb 
against a nine-amino acid determinant (HA1 98-106) that is 
completely buried in the trimer interface (referred to as the 
"interface" peptide; see Table I for peptide nomenclature [11, 
16, 22, 37]). This finding agrees well with the relatively high 
affinity of this antibody for HA1 monomeric "tops" (KA = 
106 M -1) compared with its negligible affinity for the trimer 
(KA <  104 M -1) (36). 
Other antibodies that showed significantly enhanced reac- 
tivity after low-pH treatment of BHA were those (see Table 
I) against the COOH-terminus of HA1 (C-HA1),  the amino 
terminus of HA2  (the "fusion" peptide),  a  "loop" peptide 
which is  embedded  in  the  fibrous  stem of the  trimer,  a 
"hinge" peptide located in antigenic site C, a "tip" peptide lo- 
cated in antigenic site B near the trimer interface, a "top" pep- 
tide found in antigenic site D in the subunit interface of the 
globular heads, and a peptide that extends from the stem to 
the hinge region (HA1, residues 38-64)  0  . Calculations of the 
surface-accessible area (4) using a 6-A probe showed that 
all of these peptides are either completely (e.g., the interface 
peptide) or partially (e.g., the loop peptide) buried in the na- 
tive trimer interface (see Fig.  1 B, top; additional data not 
shown). 
Whereas some of the antisera that bound preferentially to 
The Journal of Cell Biology,  Volume 105, 1987  2888 Figure 1. (Left) The location on the schematic drawing of a BHA monomer (38) of the peptide sequences that are the most reactive at low 
pH. The antibodies are directed against HA1 98-106 (purple), HA1 305-328  (green), HA2 1-15 (orange), HA1 14-52 (cyan), HA1 266-302 
(red), and HA1 201-227 (dark blue,  top). Arrows represent  13-structure and rods represent or-helices. Color code is the same as in Fig. 
6. (Right) Location and surface accessibility of some of the peptides used in this study. The a-carbon monomer HA coordinates of Wilson, 
Skehel, and Wiley (38, Brookhaven protein structure data bank) are shown in yellow; the peptide sequence used to generate the antibodies 
is in red.  The surface-accessible  area in the trimer (4) for a 6-A probe is represented by blue dots and the area buried in the trimer is 
shown in red dots. Peptide sequences buried in the monomer have no dots. Conformational changes either by trimer disassembly of the 
globular heads (e.g., 98-106), or by peptide released from the trimer interface (e.g. HA2 1-15, HA1 14-52) would result in increased exposure 
of these peptides and more accessibility for antibody binding. Top panel is arranged (left to right) according to increased antibody reactivity 
to low pH vs. neutral pH BHA (as in Table I). Bottom panel shows those peptides with essentially no difference in antibody reactivity 
to neutral or low-pH BHA. 
low-pH-treated BHA showed maximum binding to BHA that 
had been pretreated at pH 5  (e.g., the antibody against the 
fusion peptide), others (e.g., the mAb against the interface 
peptide) showed stronger reactivity with BHA that had been 
pretreated at pH 4.6.  The former antisera are all against pep- 
tides located in the stem region of the molecule, whereas the 
latter  are  all  against  peptides  found  in  the  head  or hinge 
regions of the trimer (Table I, Fig.  1 A). 
The data presented in Table I were obtained using fixed di- 
lutions of antisera (1:30 for the polyclonal antisera and 1:300 
for the monoclonal ascites fluid) and under one set condition 
of precipitation optimized for the anti-viral antiserum. This 
was done for comparative purposes both among the different 
anti-peptide antisera and especially for comparison with the 
anti-virus  antiserum.  Several  of the  anti-peptide  antisera 
could precipitate more low-pH-treated BHA by varying the 
precipitation conditions. For example, for the four most ex- 
tensively studied  sera,  the maximum amounts of low-pH- 
treated BHA precipitated in one round of solution immuno- 
precipitation were 36%  with the antiserum to the interface 
peptide, 75 % with the antiserum to the C-HA1 peptide, 39 % 
with the antiserum to the fusion peptide, and 44 % with an 
antiserum  generated  against  the  uncoupled  loop  peptide. 
Moreover, with the antibodies against the interface peptide 
and the  C-HA1  peptide,  higher precipitation  values (89% 
and  92%,  respectively) were obtained  when  precipitating 
low-pH-treated  [35S]methionine-labeled  CHA  from  solu- 
tion. Whether the higher degree of precipitation of CHA as 
compared with BHA was due to differences in the manner 
in which these molecules were radiolabeled, due to differ- 
ences in the concentration of BHA vs. CHA in our reactions 
(see Methods), or whether it is a further reflection of subtle 
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[~'JI]BHA (% precipitated) 
Antibody*  Residues  Location  Name  pH 4.6  pH 5.0  pH 7 
Virus  HAl  Site  A/B  Virus  81.4  93.8  92.1 
H26DO8  HA1  (98-106)  Head  Interface  33.6  17.5  0.1 
20  HAl  (305-328)  Stem  C-HA1  58.2  50.7  15.6 
24  HA2 (1-29)  Stem  Fusion  27.2  28. t  0.5 
3  HA1 (14-52)~  Stem  Loop  1  ! .6  11.1  0.5 
23  HA1 (266-302)~  Hinge (site C)  Hinge  10.6  4.8  0.5 
19  HA1 (201-227)  Head (site D)  Top  8.6  3.9  1.0 
17  HA1 (174-197)  Head (site B)  Tip  7.7  4.5  0.7 
4  HA1 (38-64)~  Hinge  -  5.1  2.4  0.6 
1  HAl (1-15)~  Stem  N-HAl  7.5  7.6  6.4 
25  HA2 (15-29)  Stem  -  6.4  6.0  6.6 
2  HA1 (1-39)r  Stem  -  2.7  2.3  1.2 
11  HA1 (105-139)  Head (site A)  -  1.4  1.1  0.7 
15  HA1 (140-156)  Head  -  0.9  1.0  0,5 
5  HAl (53-60)  Head  -  0.9  0.4  0.3 
Solutions of BHA were incubated at the indicated pH values for 15 min at 25~  reneutralized, and then immunoprecipitated as described in the Methods section, 
The data shown are for a 1:300 dilution of monoclonal ascites fluid (antibody  H26D08) and for 1:30 dilutions of the rabbit polyclonal antisera (all others). Values 
are the averages of at least four determinations. SD, 0,1-5.0%, 
* Nomenclature for the anti-peptide antisera according to references 16 and 37. Site A, B, C, and D refer to the antigenic sites of the HA as defined in reference 35. 
$ Contains Asn-X-Ser/Thr sequences which are glycolysated in A/Aichi/2/1968 (31). 
differences between BHA and CHA, as suggested from other 
studies (7, 9, 25) remains to be determined. 
Another finding depicted in Table I is that all of the an- 
tisera that reacted to the same extent with neutral and low- 
pH-treated BHA are directed against peptides which lie al- 
most exclusively on the surface of the HA trimer (Table I, 
Fig. 1 B, bottom). These include antibodies directed against 
the amino terminus of HA1 (N-HA1, residues  1-15), a pep- 
tide in antigenic site A (HA1 residues 105-139),  a peptide in 
the globular heads between  sites A  and B  (HA1  residues 
140-156),  and residues 15-29 of HA2. The fact that we saw 
a change in reactivity of HA2 residues 1-29 whereas we saw 
no difference in the reactivity of HA2 residues 15-29 allowed 
us to localize the major change in the fusion peptide region 
to residues 1-15, precisely those amino acids that are buried 
most deeply in the trimer interface (38). 
One should note that only a few of the anti-peptide anti- 
bodies were able to immunoprecipitate native pH 7  BHA 
trimers. These were the antibodies against the amino- and 
carboxy-terminal  peptides  of  HA1  and  against  residues 
15-29 of HA2. Even these precipitated less native pH 7 BHA 
trimers (6, 16, and 7 %, respectively) compared with a poly- 
clonal anti-X:31 viral antiserum (>90% pH 7 timers precipi- 
tated).  Interestingly,  up to 30%  of the CHA trimers have 
been precipitated with the C-HA1 antibody (see Fig.  5 D, 
legend, and Discussion). 
A further demonstration of the enhanced reactivity of sev- 
eral antisera with peptides that lie partially or completely in 
the subunit interface is shown in Fig. 2. Three of the antisera 
depicted  showed background  binding  to  neutral-pH BHA 
trimers  irrespective of the concentration  of the antiserum 
used. These were the antisera against the interface (Fig. 2 a), 
fusion (Fig. 2 b), and loop (Fig. 2 c) peptides. All of these 
showed enhanced reactivity with pH 5-treated BHA. The se- 
rum dilutions  for half-maximal binding  (to low-pH BHA) 
a 
4O 
Interface 
2C 
1C 
pH  7.0 
2  3  4  5 
log  Ab  dilution 
1C 
A  loop 
41 
I  2  3  4 
tog  Ab  dd~.ltiOn 
b 
fusion 
,0 
2O 
10 
pH  70 
I  2  3  4 
log  Ab  dilution 
d 
70 
C-HA1 
pH  5 
3O 
10F 
t  2  3  4  5 
log  Ab  dilution 
Figure 2. Titration curves for anti-peptide antisera binding to neu- 
tral  and  low-pH-treated  BHA  trimers.  Incubations  containing 
[~zSI]BHA were either left at neutral pH (solid symbols) or acidi- 
fied (open symbols) to either pH 4.6 (a) or pH 5.0 (b, c, and d) for 
15 min at room temperature, reneutralized, incubated with the indi- 
cated dilution of the antibodies against the "interface" peptide (a; 
A, A), the "fusion" peptide (b; m, z~), the "loop" peptide (c; *, <5), 
and the "C-HAl" peptide (d; e, o); nomenclature as in Table I, for 
2 h at room temperature and then immunoprecipitated as described 
in Methods. Similar profiles (to a, b, and c) were obtained for all 
of  the other anti-peptide antisera which showed enhanced reactivity 
with low-pH-treated  BHA (data not shown). 
The Journal of Cell Biology, Volume 105,  1987  2890 60 
8:40 
< 
g  2o 
p~s 
eO 4"C 
￿9  ZX 37"C 
pH7 
i  i  i  i 
5  10  15  20 
Time  (Hours) 
Figure 3.  Time and temperature 
dependence  of the formation of  ioo 
immune complexes. Samples of 
[t25I]BHA were either left at neu-  ~  80 
tral pH (solid symbols) or treated  < 
at pH 5 (open symbols) for 15 min  ~  60 
at room temperature, neutralized, 
and then immunoprecipitated  with  ~  4oI- 
a  1:300 dilution of an  antibody 
against  the  COOH-terminus  of  *~  a0 
HA1. The antibody-antigen reac- 
tions  were carried  out at either  0 
4~  (e, o) or 37~  (A, zO for the 
indicated times. The immune com- 
plexes were then precipitated and 
washed as described in Methods. Superimposable data were ob- 
tained when the antibody-antigen reactions were conducted at 25 ~ 
(not shown). 
were  1:12,000  (interface),  1:90  (fusion), and  1:150 (loop), 
respectively. Although  the  antiserum  against  the  COOH- 
terminus  of  HA1  (at  high  concentration)  precipitated  a 
significant fraction of the native BHA trimers (presumably 
because the five most COOH-terminal residues of HA1 lie 
on the surface of the trimer [38]), it precipitated substantially 
more pH 5-treated BHA (Fig. 2 d). Moreover, this antise- 
rum showed a  significantly higher affinity for the low-pH 
form; the dilutions for half-maximal binding were 1:2,400 
for pH 5-treated BHA compared with  1:36 for pH 7 BHA 
trimers (Fig. 2 d). 
Experiments were carried out to show that the observed 
anti-peptide antibody binding was not a result of time- or 
temperature-dependent general denaturation of the protein 
and that the antibodies were not inducing the conformational 
change.  For  example,  at  a  1:300  dilution,  the  antibody 
against  the  COOH-terminus of HA1  showed no time  (30 
min-24 h) or temperature (4~  25~  37~  dependence for 
formation of immune complexes with either neutral or pH 
5-pretreated BHA (Fig.  3).  Similar results were obtained 
with the antibody against the interface peptide (not shown). 
In addition, the reactivity of the anti-peptide antisera actu- 
ally decreased on treatment of BHA with  SDS  (data not 
shown). 
pH Dependences of the Conformational Changes 
Having found that several of the anti-peptide antisera bound 
preferentially to the low-pH form of the HA, we next used 
these sera to analyze the pH dependences with which in- 
dividual  peptide  segments  became exposed in  conforma- 
tions suitable for antibody binding. Our results show that the 
optimum pH at which the BHA trimers had to be pretreated 
to obtain maximum reactivity was distinct for each peptide 
(Fig. 4 a). For example, half-maximal binding was obtained 
after preincubation of BHA trimers at pH 5.7 for the fusion 
peptide, pH 5.4 for the C-HA1 peptide, and pH 5.0 for the 
interface peptide  (Fig.  4  a).  As  expected,  the polyclonal 
anti-viral  antiserum  (which  recognizes  mainly  antigenic 
sites A and B, Fig. 4 a) and a monoclonal anti-viral antise- 
rum directed against site A  (data not shown) reacted with 
BHA trimers  in a  pH-independent fashion.  In all  experi- 
ments shown, the samples were reneutralized before the ad- 
dition of antibodies. The irreversible nature of the conforma- 
5.0  6.0  7.0 
pH 
b 
monomer 
thiner 
5.0  6.0  7.0 
pH 
Figure 4. (a) pH dependences of the conformational changes as re- 
vealed by enhanced anti-peptide antisera reactivity. Fig. 3 a: Ali- 
quots  of [~25I]BHA trimers  were  adjusted  to the  indicated pH 
value, incubated for 15 min at room temperature, reneutralized, and 
immunoprecipitated with the antisera against the virus (1:75), the 
fusion peptide (1:30), the C-HA1 peptide (1:300), or the interface 
peptide (1:300) as described in Methods. The data are presented as 
a percentage of the maximum amount of input [~25I]BHA  precipi- 
tated under these conditions with the indicated serum: antivirus, 
95%  ([]); anti-fusion peptide,  30%  (=);  anti-C-HA1, 64%  (o); 
anti-interface peptide, 33 % (&). (b) Comparison of the binding of 
the  mAb  against the interface peptide to BHA  monomers  and 
trimers.  Samples of BHA  monomers  (zx) or trimers  (,t)  were 
processed as described above. Data presented are the total counts 
precipitated (33 % of the input for both monomeric and trimeric 
BHA). 
tional changes,  as previously suggested from biochemical 
studies (9, 26), was confirmed by demonstrating that the pH 
dependences as assessed by anti-peptide antibody binding 
were the same whether or not the samples were reneutralized 
before immunoprecipitation (not shown). In addition, identi- 
cal pH profiles were obtained when the experiment was con- 
ducted in the absence of 0.1% NP40 (data not shown). 
The results presented in Fig. 4 b illustrate that the striking 
increase in reactivity (300-fold) of the mAb directed against 
the interface peptide is the result of low-pH-induced dissoci- 
ation of  the three globular heads. Whereas binding of  this an- 
tiserum to BHA trimers was strictly pH dependent, binding 
to either BHA monomers or to monomeric HA1 "tops" (26) 
was  pH  independent  (Fig.  4  b).  As  noted  above,  these 
findings are in agreement with our previous study showing 
that, in solution, this antibody binds to monomeric HA tops 
but not to intact trimers (36). 
For the experiments depicted in Fig. 4, samples were acidi- 
fied for 15 min at 25~  When the samples were acidified at 
37 ~ the pH dependence for the apparent exposure of the in- 
terface peptide shifted '~0. 2 pH units in the more basic direc- 
tion,  with  50%  maximal  antibody binding  occurring  for 
BHA pretreated at pH 5.2. The pH dependences for the ap- 
parent exposures of the C-HA1 peptide and the fusion pep- 
tide were the same at 37~  as they were at 25~  The pH 
profile for the apparent exposure of the C-HA1 peptide was 
identical to the pH dependence previously recorded for the 
proteinase K sensitivity of BHA, and for the ability of BHA 
to bind to preformed liposomes (9, and unpublished results). 
The pH dependence for enhanced reactivity of the interface 
peptide (at 37~  coincides most closely with the actual pH 
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Figure 5. Kinetics of the conformation- 
al changes as revealed by enhanced an- 
ti-peptide antisera reactivity. [lzSI]BHA 
(a-c) or [35S]CHA (d) containing mix- 
tures were adjusted to pH 5.0 at 25~ 
(a), pH 5.0 at 37~  (b and d), or pH 4.8 
at 37~  (c). Samples were withdrawn at 
the indicated times, reneutralized, and 
immunoprecipitated  as described  in Meth- 
ods. Antisera dilutions for the antibodies 
against the fusion peptide, the C-HA1 
peptide, and the interface peptide were 
as indicated for the data in Fig. 4 a. For 
the additional antisera tested, the follow- 
ing dilutions were used: antiloop, 1:30; 
antihinge, 1:30; antitop, 1:75. As in Fig. 
4 a, the data are plotted as percentage of 
the maximum amount of BHA or CHA 
precipitated by a given serum. For BHA 
trimers  these values were:  anti-fusion 
peptide, 30%; anti-C-HAl peptide, 64%; 
anti-interface  peptide, 33%;  anti-loop 
peptide, 13 %; anti-hinge peptide, 14 %; 
anti-top peptide,  9%.  For the experi- 
ments  with  [35S]CHA trimers  (d),  in 
addition to the preprolactin control values, the amount of pH 7 CHA trimers precipitated were also subtracted (anti-C-HAl, 28%; anti-fu- 
sion peptide, 1%; anti-interface peptide, 1%). The maximum amounts of pS]CHA precipitated were: anti-fusion peptide, 30%; anti-C- 
HA1, 92%; and anti-interface peptide, 89%. Symbols for the different sera are listed as an inset in d. 
dependence for cell-cell fusion of BHK cells (at 37~  with 
the X:31  strain of influenza virus (9). 
Kinetics of the Conformational Changes 
To analyze the apparent kinetics of the conformational changes, 
BHA (Fig. 5, a-c) or CHA (Fig. 5 d) trimers were treated 
at pH 5, 25~  (Fig. 5 a), pH 5, 37~  (Fig. 5, b and d), or 
pH 4.8, 37~  (Fig. 5 c). At the specified time intervals, ali- 
quots were withdrawn, immediately reneutralized, and im- 
munoprecipitated with the indicated antisera.  Because the 
maximum amount of HA precipitable by the different sera 
differed greatly (see also Table I),  the data have been ex- 
pressed as the percentage of the maximum amount of low- 
pH-treated HA precipitated. Presentation of the data in this 
fashion was justified based on experiments that indicated that 
the differences in the maximum amount of HA precipitated 
by the different antisera likely reflect differences in the affini- 
ties of the sera for low-pH-treated HA rather than heteroge- 
neity of the HA molecules. Firstly, sequential precipitations 
with the same antibody consistently precipitated additional 
HA. Secondly, immunoprecipitations with combinations of 
the different sera never precipitated a higher percentage of 
HA than either antiserum alone (data not shown). This latter 
finding suggested that the population of low-pH-treated HA 
molecules was not heterogeneous. Therefore, the data should 
accurately reflect the time required at low pH to expose the 
peptides in conformations suitable for antibody binding. 
At 25~  pH 5, the half times for apparent exposure of the 
fusion peptide and the COOH-terminus of HA1 were 15 and 
30 s, respectively. The interface peptide apparently became 
exposed with a half-time of'~50 min after a lag of 5 min (Fig. 
5  a).  Whereas  the  half-times  for exposure of the  fusion 
peptide and the COOH-terminus of HA1 were relatively un- 
changed by elevating the temperature to 37~  the half-time 
for apparent exposure of the interface peptide was signifi- 
cantly reduced from 50 min at 25~  (Fig. 5 a) to 4 min at 
37~  (Fig. 5 b). At pH 4.8, 37~  the half-time for exposure 
of the interface peptide was further decreased to 45 s (Fig. 
5 c). The predicted correlation between the pH dependences 
and the kinetics of the conformational changes as monitored 
by anti-peptide antibody binding was confirmed. For exam- 
ple, the fusion peptide became exposed for reaction with its 
corresponding  antiserum  at  both  a  higher  pH  and  more 
quickly than the interface peptide (Figs. 4 a  and 5). 
We also characterized the apparent kinetics for the release 
of three other peptides: the loop peptide (located in the stem 
interface), the top peptide (located in the globular head inter- 
face), and the hinge peptide (located in the hinge region). 
Based on the crystal structure of the BHA trimer (38) we 
had predicted: (a) to observe greater reactivity of the HA1 
COOH-terminus, the loop peptide would have to move out 
from the trimer interface before and in addition to the fusion 
peptide, and (b) if the globular heads of the molecule open 
up by bending about the hinge region, then the kinetics with 
which the hinge peptide, the top peptide, and the interface 
peptide become more accessible for antibody binding should 
be similar. Indeed, the loop peptide became accessible mea- 
surably sooner than the COOH-terminus of HA1.  At pH 5, 
37~  the half-time for the loop peptide was 7.5 s whereas 
the half-time for the C-HA1 peptide was 30 s (Fig. 5 b). As 
demonstrated at both 25~  (Fig. 5 a), and at 37~  (Fig. 5 
b), the hinge, interface, and the top peptides apparently be- 
came exposed (in conformations suitable for antibody bind- 
ing) in concert, suggesting that a single major low-pH-in- 
duced structural alteration in the BHA could be responsible 
for the increased antibody binding to discrete regions within 
the globular heads.  Because three different probes for the 
globular head region required that the HA be acidified for 
similar lengths of time to obtain maximal antibody binding, 
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accessibility rather than additional low-pH-induced changes 
in peptide structure required for optimal interaction with the 
corresponding peptide antiserum. 
Because BHA appears to behave differently in some sub- 
tle, as yet unidentified ways from CHA in response to low 
pH (7, 9, 25), the kinetics of the apparent exposure of several 
peptides were compared for BHA and CHA trimers. The rel- 
ative order for the exposure of these peptides was indeed 
found to be the same for both CHA and BHA trimers (Fig. 
5 d).  Although the half-times for apparent exposure of the 
fusion and C-HA1 peptides were somewhat slower for CHA 
than for BHA, the half-time for apparent exposure of the in- 
terface peptide at pH 5, 37~  was the same, 4 min, for CHA 
and BHA trimers. 
Steps in the Conformational Change 
These data suggest a possible unfolding pathway for the low- 
pH-induced conformational changes in the HA. There ap- 
pear to be two major aspects of the transition in which struc- 
tural alterations in the stem region are followed by changes 
in the globular head region of the trimer (Fig. 6). In the first 
step,  the stem interface loop becomes more accessible, im- 
plying release from the trimer interface, quickly followed by 
the fusion peptide. These changes would expose more resi- 
dues of the COOH-terminus of HA1 (Fig. 6 b).  Sometime 
later, a second step occurs in the globular heads of the trimer 
such that the interface, top, and tip peptides become more 
accessible to their corresponding antisera; in this manner 
more of the hinge region would be exposed (Fig. 6 c). The 
results presented in Fig. 5 indicate that this second major 
step in the conformational change is highly dependent on 
both temperature and pH; it occurs faster at 37~  than at 
25~  (Fig. 5 b vs. Fig. 5 a) and faster at pH 4.8 than at pH 
5.0 (Fig. 5 c vs. Fig. 5 b). We would like to emphasize that 
Fig. 6, a-c are intended to be highly schematic and represent 
only a working model based on how the three-dimensional 
structure of the intact trimer would have to change to account 
for the anti-peptide antibody binding data. Nonetheless, the 
sequence of  changes that we have proposed is sterically feasi- 
ble based on examination of the three-dimensional structure 
of the neutral pH trimer (38).  Moreover, the alterations we 
have monitored here are in agreement with those postulated 
from prior investigations (7,  17, 25).  It is likely that other 
changes occur in the molecule that we have not detected in 
this study, either because certain segments of the protein 
might be  masked by carbohydrate (27) or due to  lack of 
anti-peptide antibody probes.  For example,  Helenius and 
co-workers favor a model where the coiled-coil alpha helices 
in the HA2 stem interface (for which we do not have a probe) 
dissociate upon acidification (7,  8). 
Discussion 
The low-pH-induced conformational change that activates 
the membrane fusion function of the influenza virus hemag- 
glutinin (HA) has been the subject of extensive investigation 
(5-9,  14,  17, 25, 26, 32, 33, 39).  These studies have led to 
a model in which the heads of the HA trimer come apart but 
remain globular, the stem region remains trimeric with some 
thinning, and no major alterations occur in overall secondary 
structure (7, 9, 17, 25, 26). In this study, we have used a panel 
of 14  anti-HA-peptide  antibodies to  compare the  surface 
structures of the native neutral-pH trimers and the low-pH 
conformation of the molecule. The results obtained by this 
analysis are fully consistent with the model arrived at by 
more conventional approaches. We believe that this excellent 
agreement validates the approach taken here and shows the 
utility of anti-peptide antibodies as probes for protein con- 
formational changes. 
By using anti-peptide antibodies, we have been able to ex- 
tend the prior observations in two ways. Firstly, due to the 
defined specificities of the anti-peptide antibodies, we have 
been able to identify more precisely the regions of the HA 
which change in response to low pH. For example, we have 
provided the most definitive evidence that the fusion peptide 
comes out from the trimer interface and identified for the 
first time a similar conformational change for the loop pep- 
tide. Lysine 27 of this loop was previously shown to be sus- 
ceptible to trypsin cleavage only after low-pH treatment (26). 
Secondly, by using these probes in kinetic studies we have 
been able to dissect the conformational change (previously 
envisioned as a concerted process) into at least two major 
transitions,  with  changes  in  the  stem  region  (Fig.  6  b) 
preceding changes in the globular head region (Fig. 6 c). 
The role of these conformational changes in viral fusion 
events is still largely unknown. Although isolated BHA and 
CHA respond to acidification in a manner similar to HA in 
the virus membrane (9, 25), the possibility still exists that 
the changes that we and others (5-9, 25, 26, 32, 39) have ob- 
served with isolated HA molecules in solution may be differ- 
ent for viral HA and/or when a virion confronts the target 
membrane in an in vivo fusion situation. To the extent that 
we can extrapolate from experiments in solution to the in 
vivo fusion reaction, a notable finding is that both in terms 
of its pH dependence and its kinetics, the fusion peptide ap- 
peared to be liberated from the stem trimer interface rela- 
tively early in the conformational change. This observation 
supports two previous speculations. (a) The fusion peptide 
may require additional pH-dependent modifications to initi- 
ate a  fusion reaction (14, 19,  20).  (b)  Dissociation of the 
globular heads may be required for membrane fusion to oc- 
cur (8, 26, 34). 
At pH 5 and 37~  conditions optimal for promoting exten- 
sive membrane fusion with the X:31 influenza virus (9), the 
globular heads appeared to separate from each other some- 
what slowly (half-time, ~4 min) compared with the kinetics 
of fusion (half-time, •30  s for the X:47 influenza virus at 
pH 5 [28]).  However, by reducing the pH to 4.8 (where full 
fusion activity can still be obtained [9, 28]), we recorded ki- 
netics for the dissociation of the globular heads (half-time, 
45 s) in good agreement with the fusion kinetics. Perhaps 
this stage of the conformational change occurs more rapidly 
at pH 5 in virions and/or in the presence of a target mem- 
brane. Alternatively, the globular heads may have to separate 
further to permit antibody binding  than to  allow  fusion. 
These speculations warrant future investigations. 
Perhaps more important than their relevance to membrane 
fusion, our results have implications regarding the use of 
anti-peptide antibodies in general and as probes for protein 
conformational changes.  Regarding  the  general  usage  of 
anti-peptide  antibodies,  two  important  findings  emerged 
from this study. Firstly, compared with a polyclonal anti-vi- 
ral antiserum, the anti-HA-peptide antibodies (even those 
directed against accessible sites) were not as efficient at pre- 
cipitating neutral pH 7 trimers.  This result was not unex- 
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tion of the low-pH-induced con- 
formational  changes  in  the  HA 
detected with  anti-peptide anti- 
bodies. Depicted are the neutral 
pH form (top),  a proposed inter- 
mediate (middle), and a proposed 
low-pH form (bottom).  As noted 
in  the  text,  additional  changes 
most likely  occur. The peptides in 
the stem region are proposed to 
be  exposed  first  (loop  peptide, 
cyan;  fusion  peptide,  orange; 
C-HAl peptide, light green) fol- 
lowed by peptides in the trimeric 
globular heads (top peptide, dark 
blue;  interface  peptide, purple) 
which separate by bending at the 
hinge region (hinge peptide, red). 
Peptide color code is similar to 
Fig. 1. The molecular coordinates 
are enclosed in spheres and cylin- 
ders to emphasize the highly sche- 
matic nature of this figure. 
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monovalent  compared with the multivalency of polyclonal 
anti-protein antibodies. Other factors may contribute to the 
poorer reaction of the anti-peptide antibodies with neutral 
pH HA. For example, there are several amino acid changes 
in the major antigenic sites (A-D) between the X:47 and the 
X:31 viruses (2, 21, 31, 35). One should note that high-affin- 
ity anti-peptide antibodies can be generated. The mAb used 
in this study represents  one of a panel of high-affinity anti- 
peptide antibodies (KA  =  108 M -j for peptide;  KA  =  106 M -1 
for protein [HA "tops" 36]). Moreover, in a recent study of 
the antigenic sites of myohemeryrthrin it was found that four 
out of six monoclonal anti-peptide antibodies bound the in- 
tact protein with equal or higher affinity than an anti-protein 
antibody reactive with the same region of the molecule (12). 
A second finding regarding the general use of anti-peptide 
antibodies is that our results on the ability of the anti-peptide 
antisera  to immunoprecipitate pH 7 trimers appear  to con- 
flict with the strong  reaction observed with the same anti- 
sera  in solid phase assays  (16, 22,  37).  This  is especially 
pronounced for antibodies directed against parts of the mole- 
cule that are buried in the trimer.  In light of the findings 
presented here the behavior of the HA in solid-phase assays 
is more easily understood. Given that the HA is designed to 
partially dissociate, then it may do so (even at pH 7) when 
attached to a solid support. (This possibility was raised pre- 
viously [37].) Although we cannot generalize our results  to 
other proteins, our data highlight the necessity to conduct 
analyses  in  solution  when examining  questions  of protein 
conformation. 
Several  findings  regarding  the  use  of anti-peptide  anti- 
bodies  as  probes  for protein conformational  changes  also 
emerged from this study. Most importantly,  we observed that 
once the HA was allowed to undergo its fusion-inducing con- 
formational change, several  antisera  (those directed against 
peptides that lie either completely or partially  in the trimer 
interface)  reacted  more  extensively,  and  in  several  cases 
quite well, with the HA. This finding highlights the obvious 
importance of the accessibility of any given peptide sequence 
in a protein for reaction with its corresponding anti-peptide 
antiserum.  However, our data also show that among those 
antisera that reacted preferentially with low-pH-treated HA, 
both the maximum amount of low-pH HA precipitable as 
well as the apparent affinity of the anti-peptide antibodies for 
low-pH HA differed greatly for different sera. These obser- 
vations strongly suggest that additional factors,  such as local 
peptide unfolding or changes in mobility (15, 30), contribute 
to the overall reactivity between the anti-peptide antisera and 
the intact protein. In this respect it is worthy of note that at 
both neutral and low pH, the most reactive peptides are those 
which are both surface accessible and either (a) 'untethered' 
(e.g.,  terminal  peptides) or (b) not highly structured  (e.g., 
the interface peptide). 
In summary,  we have documented the use of anti-peptide 
antibodies  for studying  low-pH-induced  alterations  in the 
influenza  virus  hemagglutinin.  Schoolnik  and  co-workers 
have reported a similar use of anti-peptide antisera  in their 
studies on calmodulin.  They  found differential binding of 
four polyclonal  anti-peptide  antisera  to calmodulin  in  its 
Ca2+-free compared with its Ca2§  form (13).  Col- 
lectively our data suggest that anti-peptide antibodies can be 
powerful reagents  for monitoring the structural  details and 
dynamics of certain  biologically important  protein confor- 
mational  changes (1,  18, 40).  This type of analysis will be 
most meaningful when the three-dimensional  structure of at 
least one comformational  state of the protein of interest is 
known. 
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